Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-16Clinical Trial Update: Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer [Phase 2]
A Phase 2 trial evaluating sequential all-trans retinoic acid (ATRA) followed by interleukin-2 (IL-2) to modulate dendritic cells for treati…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating sunitinib malate given before and after surgery in patients with …
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer [Phase 3]
A Phase 3 trial evaluating sorafenib for patients at risk of relapse after nephrectomy for renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer [Phase 2]
Phase 2 trial update examining MRI-detected blood vessel changes in patients with stage III or IV renal cell carcinoma treated with bevacizu…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab in combination with interleukin-2 for metastatic or recurrent renal cell carcinoma; results were posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 randomized dose-escalation trial of sorafenib in patients with previously untreated metastatic renal cell carcinoma. The study was t…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [Phase 1]
A Phase 1 study evaluated intravenous interleukin-4 PE38KDEL cytotoxin in patients with recurrent or metastatic breast cancer, renal cell ca…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment [Phase 2]
A Phase 2 trial evaluating the biologic activity and safety of an immunotherapeutic in newly diagnosed advanced renal cell carcinoma, tested…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers [Phase 1]
Phase 1 study evaluating the combination of nelfinavir and temsirolimus in patients with advanced cancers, including renal cell carcinoma, h…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. [Phase 3]
A Phase 3 trial evaluating low-dose interleukin-2 plus interferon-alpha as adjuvant immunotherapy for renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating sorafenib in combination with interferon alfa-2b for locally advanced or metastatic renal cell carcinoma; …
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Bryostatin 1 In Treating Patients With Progressive Kidney Cancer [Phase 2]
A Phase 2 trial evaluating Bryostatin-1 in patients with progressive kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial update evaluating a combination of biological therapy and chemotherapy for metastatic colorectal cancer and metas…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update of tanespimycin (17-N-Allylamino-17-Demethoxygeldanamycin) in patients with metastatic renal cell carcinoma; t…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of flavopiridol for unresectable or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating 6-Hydroxymethylacylfulvene (Irofulven) in patients with meta…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Phase I Study of Vorinostat and Sorafenib in Advanced Cancer [Phase 1]
Phase I study update of the combination of vorinostat and sorafenib in patients with advanced cancer, with completed status. Diseases includ…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer [Phase 2]
Phase 2 study of denileukin diftitox in metastatic melanoma or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide for metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Caspofungin Acetate in Treating Children With Fever and Neutropenia [NA]
An update on a completed clinical trial evaluating caspofungin acetate for treating infections in pediatric patients with fever and neutrope…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 randomized trial comparing pazopanib to sunitinib in first-line locally advanced or metastatic renal cell carcinoma has completed, w…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 3]
Phase 3 trial evaluating interleukin-2 for metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer [Phase 3]
A Phase 3 trial sponsored by the European Organisation for Research and Treatment of Cancer compared kidney-sparing surgery with radical nep…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC [Phase 2]
Phase 2 clinical trial evaluating a dendritic cell vaccine with IL-2 and interferon-alpha-2a in metastatic renal cell carcinoma. Results wer…